FPHAF
Price:
$3.3
Market Cap:
$234.49M
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company develops a pipeline of immune modulation based proprietary drug candidates for unmet need, including immuno-oncology, and organ protection and regenerative medicine. Its lead product candidates are Traumakine, an intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies. The company also de...[Read more]
Industry
Biotechnology
IPO Date
2020-04-28
Stock Exchange
OTC
Ticker
FPHAF
According to Faron Pharmaceuticals Oy’s latest financial reports and current stock price. The company's current PE Ratio is -7.50. This represents a change of -99.69% compared to the average of -2402.24 of the last 4 quarters.
The mean historical PE Ratio of Faron Pharmaceuticals Oy over the last ten years is -852.85. The current -7.50 PE Ratio has changed -12.06% with respect to the historical average. Over the past ten years (40 quarters), FPHAF's PE Ratio was at its highest in in the January 2012 quarter at 0. The PE Ratio was at its lowest in in the December 2014 quarter at -28749.01.
Average
-852.85
Median
-7.96
Minimum
-8457.93
Maximum
-0.95
Discovering the peaks and valleys of Faron Pharmaceuticals Oy PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 111.97%
Maximum Annual PE Ratio = -0.95
Minimum Annual Increase = -92.42%
Minimum Annual PE Ratio = -8457.93
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -8457.93 | 111.97% |
| 2023 | -7.55 | 15.35% |
| 2022 | -6.54 | -14.37% |
| 2021 | -7.64 | -3.01% |
| 2020 | -7.88 | -5.60% |
| 2019 | -8.34 | 781.61% |
| 2018 | -0.95 | -92.42% |
| 2017 | -12.49 | 55.11% |
| 2016 | -8.05 | -27.76% |
| 2015 | -11.14 | -81.67% |
The current PE Ratio of Faron Pharmaceuticals Oy (FPHAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2824.01
5-year avg
-1697.51
10-year avg
-852.85
Faron Pharmaceuticals Oy’s PE Ratio is less than AnGes, Inc. (-0.72), less than Recce Pharmaceuticals Ltd (-7.03), greater than Adocia S.A. (-11.89), less than Planet 13 Holdings Inc. (-1.22), less than Newron Pharmaceuticals S.p.A. (15.71), less than Eupraxia Pharmaceuticals Inc. (-6.47), greater than Broncus Holding Corporation (-10.21), greater than Volpara Health Technologies Limited (-32.34), greater than Adocia S.A. (-11.89), less than Prescient Therapeutics Limited (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.72 | $139.07M | |
| -7.03 | $76.55M | |
| -11.89 | $170.44M | |
| -1.22 | $202.02M | |
| 15.71 | $239.53M | |
| -6.47 | $108.29M | |
| -10.21 | $42.11M | |
| -32.34 | $188.24M | |
| -11.89 | $103.66M | |
| 0 | $117.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Faron Pharmaceuticals Oy using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Faron Pharmaceuticals Oy or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Faron Pharmaceuticals Oy's PE Ratio?
How is the PE Ratio calculated for Faron Pharmaceuticals Oy (FPHAF)?
What is the highest PE Ratio for Faron Pharmaceuticals Oy (FPHAF)?
What is the 3-year average PE Ratio for Faron Pharmaceuticals Oy (FPHAF)?
What is the 5-year average PE Ratio for Faron Pharmaceuticals Oy (FPHAF)?
How does the current PE Ratio for Faron Pharmaceuticals Oy (FPHAF) compare to its historical average?